MyChem

San Diego, United States Founded: 2007 • Age: 19 yrs Acquired By Maravai Life Sciences
Diversified nucleotides are manufactured by MyChem for biotech applications.
Request Access

About MyChem

MyChem is a company based in San Diego (United States) founded in 2007 by Chanfeng Zhao and Tao Jiang was acquired by Maravai Life Sciences in January 2022.. MyChem offers products and services including Ultra-Pure Nucleotides, dNTPs, Modified Triphosphate, Phosphoramidite, and Nucleosides.

  • Headquarter San Diego, United States
  • Founders Chanfeng Zhao, Tao Jiang
  • Sectors
    Chemicals & Materials
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Legal Name Mychem, Llc
Operational Areas
Chemicals & Materials → Specialty & Industrial Chemicals
Key Metrics
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of MyChem

MyChem offers a comprehensive portfolio of products and services, including Ultra-Pure Nucleotides, dNTPs, Modified Triphosphate, Phosphoramidite, and Nucleosides. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Provides high-purity options for next-generation sequencing applications.

Enhances assay performance and simplifies quality control processes.

Offers synthetic modifications for advanced molecular biology uses.

Supports nucleotide synthesis at multi-kilogram scales.

Delivers pure compounds for research and sequencing needs.

Funding Insights of MyChem

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in MyChem

MyChem has secured backing from 1 investor. Prominent investors backing the company include Maravai Life Sciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Provides enabling tools and services in the life sciences research and bio-production industries
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by MyChem

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - MyChem

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Mychem Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of MyChem

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Mychem

Frequently Asked Questions about MyChem

When was MyChem founded?

MyChem was founded in 2007.

Where is MyChem located?

MyChem is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Who is the current CEO of MyChem?

Carl Hull is the current CEO of MyChem.

What does MyChem do?

MyChem was established in 2007 in San Diego, United States, by founders Chanfeng Zhao and Tao Jiang. Diversified nucleotides are produced by the company, which operates within the biotechnology and chemical manufacturing sectors. Core activities center on the synthesis and supply of these compounds for research and industrial uses. Leadership roles are filled by CEOs Carl Hull and Rick Hogrefe, overseeing operations from the U.S. base.

What products or services does MyChem offer?

MyChem offers Ultra-Pure Nucleotides, dNTPs, Modified Triphosphate, Phosphoramidite, and Nucleosides.

Who are MyChem's investors?

MyChem has 1 investor. Key investors include Maravai Life Sciences.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available